Warberg Asset Management’s Lixte Biotechnology Holdings, Inc. Warrants LIXTW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-35,906
| Closed | -$1.6K | – | 192 |
|
2024
Q3 | $1.6K | Sell |
35,906
-1,968
| -5% | -$88 | ﹤0.01% | 157 |
|
2024
Q2 | $2.26K | Sell |
37,874
-3,001
| -7% | -$179 | ﹤0.01% | 171 |
|
2024
Q1 | $2.05K | Hold |
40,875
| – | – | ﹤0.01% | 167 |
|
2023
Q4 | $1.53K | Hold |
40,875
| – | – | ﹤0.01% | 173 |
|
2023
Q3 | $2.58K | Sell |
40,875
-12,306
| -23% | -$775 | ﹤0.01% | 189 |
|
2023
Q2 | $3.71K | Hold |
53,181
| – | – | ﹤0.01% | 172 |
|
2023
Q1 | $4.58K | Buy |
+53,181
| New | +$4.58K | ﹤0.01% | 187 |
|
2022
Q3 | – | Sell |
-12,000
| Closed | -$2K | – | 275 |
|
2022
Q2 | $2K | Sell |
12,000
-21,203
| -64% | -$3.53K | ﹤0.01% | 213 |
|
2022
Q1 | $8K | Buy |
33,203
+15,269
| +85% | +$3.68K | ﹤0.01% | 186 |
|
2021
Q4 | $8K | Sell |
17,934
-18,062
| -50% | -$8.06K | ﹤0.01% | 168 |
|
2021
Q3 | $20K | Buy |
35,996
+21,642
| +151% | +$12K | ﹤0.01% | 157 |
|
2021
Q2 | $11K | Sell |
14,354
-12,246
| -46% | -$9.39K | ﹤0.01% | 162 |
|
2021
Q1 | $22K | Buy |
26,600
+13,599
| +105% | +$11.2K | 0.01% | 114 |
|
2020
Q4 | $12K | Buy |
+13,001
| New | +$12K | ﹤0.01% | 103 |
|